70%Confidence
0Views
FDASource
2026-03-07Date
Summary
Pro Numb Tattoo Numbing Spray faces cGMP deviations, indicating quality control failures that could lead to market withdrawal and regulatory penalties. This highlights risks in the cosmetic/tattoo numbing product sector and may prompt increased FDA oversight of topical anesthetics.
Actionable: Avoid investment in unregulated topical anesthetic companies until cGMP compliance is demonstrated.
AI Confidence: 70%
Data Points
firmPro Numb Tattoo Numbing Spray LLC
classificationClass II
statusOngoing
distributionNationwide in the USA
productPro Numb Tattoo Numbing Spray, 5% Lidocaine, [1 FL OZ/28.4 ML or 4 oz/120 mL] per bottle, Distributed by: Pro Numb Tattoo numbing spray LLC, Melbourne
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now